BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Science in Boston - ECPv6.17.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Science in Boston
X-ORIGINAL-URL:https://scienceinboston.com
X-WR-CALDESC:Events for Science in Boston
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Toronto
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20220313T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20221106T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Vancouver
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20220313T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20221106T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211026T160000
DTEND;TZID=America/Toronto:20211026T170000
DTSTAMP:20211025T180531Z
CREATED:20211022T215407Z
LAST-MODIFIED:20211025T180531Z
UID:17064-1635264000-1635267600@scienceinboston.com
SUMMARY:Biology Colloquium Series (Dr. Gene-Wei Li)
DESCRIPTION:Speaker: Dr. Gene Wei-Li\, MIT\, hosted by Alan Grossman. \nTitle: “Stoichiometric protein synthesis: requirements and mechanisms.” \nThe Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the fall school year. Contact: Margaret Cabral at mcabral1@mit.edu
URL:https://scienceinboston.com/event/biology-colloquium-series-dr-gene-wei-li/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211026T160000
DTEND;TZID=America/Toronto:20211026T170000
DTSTAMP:20211022T215407Z
CREATED:20211022T215407Z
LAST-MODIFIED:20211022T215407Z
UID:27759-1635264000-1635267600@scienceinboston.com
SUMMARY:Biology Colloquium Series (Dr. Gene-Wei Li)
DESCRIPTION:Speaker: Dr. Gene Wei-Li\, MIT\, hosted by Alan Grossman. \nTitle: “Stoichiometric protein synthesis: requirements and mechanisms.” \nThe Biology Colloquium is a weekly seminar held throughout the academic year\, featuring distinguished speakers in many areas of the biological sciences\, from universities and institutions worldwide. More information on speakers\, their affiliations\, and titles of their talks will be added as available. The Colloquium will zoom at 4:00PM  Tuesdays during the fall school year. Contact: Margaret Cabral at mcabral1@mit.edu
URL:https://scienceinboston.com/event/biology-colloquium-series-dr-gene-wei-li-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211027T160000
DTEND;TZID=America/Toronto:20211027T170000
DTSTAMP:20211022T224234Z
CREATED:20211022T224234Z
LAST-MODIFIED:20211022T224234Z
UID:17072-1635350400-1635354000@scienceinboston.com
SUMMARY:SCSB Colloquium Series – Dr. Constance Smith-Hicks
DESCRIPTION:Date: Wednesday\, October 27\, 2021\nLocation: Zoom Webinar – Registration Required\nRegister in advance for this webinar: click here\n* After registering\, you will receive a confirmation email containing information on how to join the webinar. \nSpeaker: Constance Smith-Hicks\, M.D.\, Ph.D.\nAffiliation: Director SYNGAP1 Center of Excellence\, Director Rett Syndrome Program\, Kennedy Krieger Institute; Assistant Professor of Neurology\, Johns Hopkins University. \nHost: Dr. Mriganka Sur \nTalk title: Genes and social behavior – what can we learn from monogenic disorders \nAbstract: Social behavior develops at the intersection of genetics\, environment\, and culture.  Divergent social behaviors have been reported in both polygenic and monogenic neurodevelopmental disorders\, with genes influencing behavior by their effect on brain development and function during sensitive periods. Using recent data from our work in SYNGAP1\, I’ll put forth a framework for understanding the interplay between sensory processing and social and maladaptive behaviors.
URL:https://scienceinboston.com/event/scsb-colloquium-series-dr-constance-smith-hicks/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211027T160000
DTEND;TZID=America/Toronto:20211027T170000
DTSTAMP:20211022T224234Z
CREATED:20211022T224234Z
LAST-MODIFIED:20211022T224234Z
UID:27761-1635350400-1635354000@scienceinboston.com
SUMMARY:SCSB Colloquium Series – Dr. Constance Smith-Hicks
DESCRIPTION:Date: Wednesday\, October 27\, 2021\nLocation: Zoom Webinar – Registration Required\nRegister in advance for this webinar: click here\n* After registering\, you will receive a confirmation email containing information on how to join the webinar. \nSpeaker: Constance Smith-Hicks\, M.D.\, Ph.D.\nAffiliation: Director SYNGAP1 Center of Excellence\, Director Rett Syndrome Program\, Kennedy Krieger Institute; Assistant Professor of Neurology\, Johns Hopkins University. \nHost: Dr. Mriganka Sur \nTalk title: Genes and social behavior – what can we learn from monogenic disorders \nAbstract: Social behavior develops at the intersection of genetics\, environment\, and culture.  Divergent social behaviors have been reported in both polygenic and monogenic neurodevelopmental disorders\, with genes influencing behavior by their effect on brain development and function during sensitive periods. Using recent data from our work in SYNGAP1\, I’ll put forth a framework for understanding the interplay between sensory processing and social and maladaptive behaviors.
URL:https://scienceinboston.com/event/scsb-colloquium-series-dr-constance-smith-hicks-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211028T080000
DTEND;TZID=America/Toronto:20211029T170000
DTSTAMP:20211025T182308Z
CREATED:20210722T192703Z
LAST-MODIFIED:20211025T182308Z
UID:15637-1635408000-1635526800@scienceinboston.com
SUMMARY:Forsyth Scientific Symposium: Oral Microbiome — Beyond Bacteria
DESCRIPTION:Forsyth’s annual Scientific Symposium\, Oral Microbiome: Beyond Bacteria\, aims to promote better understanding of the oral microbiome from a holistic perspective. \nThe oral microbiome is composed of diverse conventional bacterial species\, fungal and viral (bacteriophage) components\, as well as recently identified nano-sized parasitic Candidate Phyla Radiation (CPR) organisms(1-3). Effective management of oral microbiome-related diseases calls for a more comprehensive understanding of the impact of the oral microbiota on host health and disease\, which requires a holistic view of intra- and cross-kingdom interactions among members of the oral microbiome\, as well as microbial-host interaction. \nThe symposium will bring together a group of scientists with diverse research backgrounds in oral microbiome (including oral bacteriome\, mycobiome\, virome and CPR) and different career stages to share their research and ideas. \nA key objective is to identify biological questions and technical roadblocks that must be overcome to achieve a more comprehensive understanding of the impact of the oral microbiota on host health and disease from a holistic point of view. Meanwhile\, the meeting will promote collaborations and provide a great opportunity for trainees to interact with experts in the field and promote their research.
URL:https://scienceinboston.com/event/forsyth-scientific-symposium-oral-microbiome-beyond-bacteria/
LOCATION:Forsyth Institute and Online\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211028T080000
DTEND;TZID=America/Toronto:20211029T170000
DTSTAMP:20210722T192703Z
CREATED:20210722T192703Z
LAST-MODIFIED:20210722T192703Z
UID:27732-1635408000-1635526800@scienceinboston.com
SUMMARY:Forsyth Scientific Symposium: Oral Microbiome — Beyond Bacteria
DESCRIPTION:Forsyth’s annual Scientific Symposium\, Oral Microbiome: Beyond Bacteria\, aims to promote better understanding of the oral microbiome from a holistic perspective. \nThe oral microbiome is composed of diverse conventional bacterial species\, fungal and viral (bacteriophage) components\, as well as recently identified nano-sized parasitic Candidate Phyla Radiation (CPR) organisms(1-3). Effective management of oral microbiome-related diseases calls for a more comprehensive understanding of the impact of the oral microbiota on host health and disease\, which requires a holistic view of intra- and cross-kingdom interactions among members of the oral microbiome\, as well as microbial-host interaction. \nThe symposium will bring together a group of scientists with diverse research backgrounds in oral microbiome (including oral bacteriome\, mycobiome\, virome and CPR) and different career stages to share their research and ideas. \nA key objective is to identify biological questions and technical roadblocks that must be overcome to achieve a more comprehensive understanding of the impact of the oral microbiota on host health and disease from a holistic point of view. Meanwhile\, the meeting will promote collaborations and provide a great opportunity for trainees to interact with experts in the field and promote their research.
URL:https://scienceinboston.com/event/forsyth-scientific-symposium-oral-microbiome-beyond-bacteria-2/
LOCATION:Forsyth Institute and Online\, 245 First Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211101T183000
DTEND;TZID=America/Toronto:20211101T193000
DTSTAMP:20211018T175117Z
CREATED:20211018T175117Z
LAST-MODIFIED:20211018T175117Z
UID:16929-1635791400-1635795000@scienceinboston.com
SUMMARY:Entrepreneurship at the Koch Institute
DESCRIPTION:Join Koch Institute investigators on Zoom for a with/in/sight event exploring the relationship between laboratory research and entrepreneurship. From drug discovery to disease detection and cancer immunotherapy\, this evening’s featured startup companies began in MIT’s academic community and are now taking the biotech world by storm. Hear from the founders themselves about why a startup was the right research move to turn innovation into impact.
URL:https://scienceinboston.com/event/entrepreneurship-at-the-koch-institute/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211101T183000
DTEND;TZID=America/Toronto:20211101T193000
DTSTAMP:20211018T175117Z
CREATED:20211018T175117Z
LAST-MODIFIED:20211018T175117Z
UID:27756-1635791400-1635795000@scienceinboston.com
SUMMARY:Entrepreneurship at the Koch Institute
DESCRIPTION:Join Koch Institute investigators on Zoom for a with/in/sight event exploring the relationship between laboratory research and entrepreneurship. From drug discovery to disease detection and cancer immunotherapy\, this evening’s featured startup companies began in MIT’s academic community and are now taking the biotech world by storm. Hear from the founders themselves about why a startup was the right research move to turn innovation into impact.
URL:https://scienceinboston.com/event/entrepreneurship-at-the-koch-institute-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211104T100000
DTEND;TZID=America/Toronto:20211104T120000
DTSTAMP:20211018T174336Z
CREATED:20211018T174336Z
LAST-MODIFIED:20211018T174336Z
UID:16926-1636020000-1636027200@scienceinboston.com
SUMMARY:MassBio Digital Health Impact 2021
DESCRIPTION:The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning\, digital technologies are easing data collection from patients\, increasing medical adherence\, supplementing clinical trials\, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes. \nJoin MassBio as we examine the current state of digital health as it relates to the life sciences\, the challenges facing its growth\, and opportunities or collaboration. Through keynotes\, panel discussions\, and case studies\, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients. Free virtual event
URL:https://scienceinboston.com/event/massbio-digital-health-impact-2021/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211104T100000
DTEND;TZID=America/Toronto:20211104T120000
DTSTAMP:20211018T174336Z
CREATED:20211018T174336Z
LAST-MODIFIED:20211018T174336Z
UID:27755-1636020000-1636027200@scienceinboston.com
SUMMARY:MassBio Digital Health Impact 2021
DESCRIPTION:The convergence between digital health and the life sciences is creating new opportunities to transform patient care as well as drug discovery and development. From wearables to machine learning\, digital technologies are easing data collection from patients\, increasing medical adherence\, supplementing clinical trials\, and offering new insights into real-world applications of therapies. Embedding digital health tools into the life sciences will also allow new therapies to better work within the growing value-based healthcare system that relies on data and measurable outcomes. \nJoin MassBio as we examine the current state of digital health as it relates to the life sciences\, the challenges facing its growth\, and opportunities or collaboration. Through keynotes\, panel discussions\, and case studies\, we’ll explore new strategies for therapeutics and digital health innovators to converge and ultimately deliver better outcomes for patients. Free virtual event
URL:https://scienceinboston.com/event/massbio-digital-health-impact-2021-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211105T080000
DTEND;TZID=America/Toronto:20211105T183000
DTSTAMP:20211022T214518Z
CREATED:20211022T214500Z
LAST-MODIFIED:20211022T214518Z
UID:17058-1636099200-1636137000@scienceinboston.com
SUMMARY:3rd Annual Health Data Science Symposium at Harvard
DESCRIPTION:You are cordially invited to the 3rd Annual Health Data Science Symposium at Harvard in Boston on Nov 5th 2021. \nHosted by the Brigham & Women’s Hospital/Harvard Medical School Dept of Neurosurgery’s Computational Neuroscience Outcomes Center & the Harvard School of Public Health Onnela Lab. \nThe symposium is In-person\, with Virtual attendance options available. Should public health guidelines change\, the symposium will become fully Virtual and 75% of the Ticket fees will be refunded. \nThe symposium brings together leading experts for a day of talks\, abstract presentations\, and collaborative networking around state-of-the-art advances across academia and industry in the health data sciences. The 2021 focus is Smartphones\, Wearables\, and Health – Digital Phenotyping & personal sensing in health. Please visit the symposium site http://hsph.me/health-data-sci-symposium for the complete Program\, Speakers\, & Abstract submission. \nRegistration is open to all clinicians\, researchers\, industry colleagues\, trainees\, & students. Reduced early registration rates available until Oct 5th\, & will rise afterwards. \nFor faculty\, postdoc/resident/fellow\, & student tickets\, you must register using your institutional email address. \nThis year’s Keynote Speakers: \nSusan K. Gregurick\, PhD; Associate Director for Data Science & Director of the Office of Data Science Strategy\, NIH \nAndrew T. Campbell\, PhD; Professor of Computer Science & Co-Director of DartNets Lab\, Dartmouth College \n\n\nSymposium Directors \nTimothy Smith\, MD MPH PhD \nBryan Iorgulescu\, MD \nJP Onnela\, PhD
URL:https://scienceinboston.com/event/3rd-annual-health-data-science-symposium-at-harvard/
LOCATION:Brigham & Women’s Hospital
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211105T080000
DTEND;TZID=America/Toronto:20211105T183000
DTSTAMP:20211022T214500Z
CREATED:20211022T214500Z
LAST-MODIFIED:20211022T214500Z
UID:27757-1636099200-1636137000@scienceinboston.com
SUMMARY:3rd Annual Health Data Science Symposium at Harvard
DESCRIPTION:You are cordially invited to the 3rd Annual Health Data Science Symposium at Harvard in Boston on Nov 5th 2021. \nHosted by the Brigham & Women’s Hospital/Harvard Medical School Dept of Neurosurgery’s Computational Neuroscience Outcomes Center & the Harvard School of Public Health Onnela Lab. \nThe symposium is In-person\, with Virtual attendance options available. Should public health guidelines change\, the symposium will become fully Virtual and 75% of the Ticket fees will be refunded. \nThe symposium brings together leading experts for a day of talks\, abstract presentations\, and collaborative networking around state-of-the-art advances across academia and industry in the health data sciences. The 2021 focus is Smartphones\, Wearables\, and Health – Digital Phenotyping & personal sensing in health. Please visit the symposium site http://hsph.me/health-data-sci-symposium for the complete Program\, Speakers\, & Abstract submission. \nRegistration is open to all clinicians\, researchers\, industry colleagues\, trainees\, & students. Reduced early registration rates available until Oct 5th\, & will rise afterwards. \nFor faculty\, postdoc/resident/fellow\, & student tickets\, you must register using your institutional email address. \nThis year’s Keynote Speakers: \nSusan K. Gregurick\, PhD; Associate Director for Data Science & Director of the Office of Data Science Strategy\, NIH \nAndrew T. Campbell\, PhD; Professor of Computer Science & Co-Director of DartNets Lab\, Dartmouth College \n\n\nSymposium Directors \nTimothy Smith\, MD MPH PhD \nBryan Iorgulescu\, MD \nJP Onnela\, PhD
URL:https://scienceinboston.com/event/3rd-annual-health-data-science-symposium-at-harvard-2/
LOCATION:Brigham & Women’s Hospital
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211109T120000
DTEND;TZID=America/Toronto:20211109T130000
DTSTAMP:20211022T225047Z
CREATED:20211022T225047Z
LAST-MODIFIED:20211022T225047Z
UID:17080-1636459200-1636462800@scienceinboston.com
SUMMARY:BioRender Webinar @ Harvard University: Design Tips for Protocol Figures
DESCRIPTION:BioRender Webinar @ Harvard University: Design Tips for Protocol Figures\n\n\nIn this one-hour webinar\, learn actionable tips and techniques for improving the layout of your next protocol figure/diagram with a brief introduction to the BioRender software. Learn how to:\n-Reduce clutter by using gridlines to space out visual elements\n-Number the steps to eliminate messy arrows\n-Use zoom-ins/call-outs to highlight details\n-And more… \nAbout BioRender: \nBioRender is the easy-to-use science illustration tool that’s quickly becoming a staple in academic institutions and labs around the world! \nYou’ve probably spent countless hours trying to create biological diagrams using Powerpoint\, Illustrator or even pen and paper. Scientists in academia\, industry\, government and publishing will inevitably require clear communication of ideas in order to advance their research and careers. \nIf you already are registered for the Harvard Premium BioRender account\, you can log in at https://app.biorender.com/portal/harvard \nIf you are a member of the Harvard Community and want a BioRender account\, you can submit the request form\, found at https://it.hms.harvard.edu/our-services/research-computing/services/research-applications-software/research-application . \n\n\n\nNov 9\, 2021 12:00 PM in Eastern Time (US and Canada)
URL:https://scienceinboston.com/event/biorender-webinar-harvard-university-design-tips-for-protocol-figures/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211109T120000
DTEND;TZID=America/Toronto:20211109T130000
DTSTAMP:20211022T225047Z
CREATED:20211022T225047Z
LAST-MODIFIED:20211022T225047Z
UID:27763-1636459200-1636462800@scienceinboston.com
SUMMARY:BioRender Webinar @ Harvard University: Design Tips for Protocol Figures
DESCRIPTION:BioRender Webinar @ Harvard University: Design Tips for Protocol Figures\n\n\nIn this one-hour webinar\, learn actionable tips and techniques for improving the layout of your next protocol figure/diagram with a brief introduction to the BioRender software. Learn how to:\n-Reduce clutter by using gridlines to space out visual elements\n-Number the steps to eliminate messy arrows\n-Use zoom-ins/call-outs to highlight details\n-And more… \nAbout BioRender: \nBioRender is the easy-to-use science illustration tool that’s quickly becoming a staple in academic institutions and labs around the world! \nYou’ve probably spent countless hours trying to create biological diagrams using Powerpoint\, Illustrator or even pen and paper. Scientists in academia\, industry\, government and publishing will inevitably require clear communication of ideas in order to advance their research and careers. \nIf you already are registered for the Harvard Premium BioRender account\, you can log in at https://app.biorender.com/portal/harvard \nIf you are a member of the Harvard Community and want a BioRender account\, you can submit the request form\, found at https://it.hms.harvard.edu/our-services/research-computing/services/research-applications-software/research-application . \n\n\n\nNov 9\, 2021 12:00 PM in Eastern Time (US and Canada)
URL:https://scienceinboston.com/event/biorender-webinar-harvard-university-design-tips-for-protocol-figures-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211110T133000
DTEND;TZID=America/Toronto:20211110T173000
DTSTAMP:20211101T175321Z
CREATED:20211015T213257Z
LAST-MODIFIED:20211101T175321Z
UID:16899-1636551000-1636565400@scienceinboston.com
SUMMARY:Microbiome in Oncology Symposium
DESCRIPTION:The Center for Microbiome Informatics and Therapeutics (CMIT) and the Koch Institute for Integrative Cancer Research (KI) will host a joint symposium on Wednesday\, November 10th\, 2021. \nThe Microbiome in Oncology Symposium will bring together researchers from KI and CMIT with varied approaches to understanding the interplay between diet and lifestyle factors\, the microbiome\, and host biology in the context of health and disease. And Senior VP of Research at Finch Therapeutics\, Dr. Sonia Timberlake\, will join us for an inspiring keynote on present opportunities for technical innovation and clinical impact at the interface of microbiome and oncology research. \nAn outdoor reception will immediately follow\, providing networking opportunities for investigators and trainees from both research centers. \nNOTE: Attendees are required to register through Eventbrite in advance. Attendance will be managed through the MIT COVIDpass system. All in-person attendees must be a registered COVIDpass user OR non-MIT affiliates must register for a Tim Ticket. \n\nProgram Overview\nKeynote Address \nSonia Timberlake\, PhD\nSenior VP of Research\, Finch Therapeutics \n\nResearch Presentations \nÖmer H. Yilmaz\, MD\, PhD\nEisen and Chang Career Development Professor\nAssociate Professor of Biology \n\nMathilde Poyet\, PhD and Mathieu Groussin\, PhD\nPost-doctoral Fellows\, MIT BE\nScientific Directors & Founders\, Global Microbiome Conservancy \n\nLaura Kiessling\, PhD\nNovartis Professor of Chemistry
URL:https://scienceinboston.com/event/microbiome-in-oncology-symposium/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211110T133000
DTEND;TZID=America/Toronto:20211110T173000
DTSTAMP:20211015T213257Z
CREATED:20211015T213257Z
LAST-MODIFIED:20211015T213257Z
UID:27754-1636551000-1636565400@scienceinboston.com
SUMMARY:Microbiome in Oncology Symposium
DESCRIPTION:The Center for Microbiome Informatics and Therapeutics (CMIT) and the Koch Institute for Integrative Cancer Research (KI) will host a joint symposium on Wednesday\, November 10th\, 2021. \nThe Microbiome in Oncology Symposium will bring together researchers from KI and CMIT with varied approaches to understanding the interplay between diet and lifestyle factors\, the microbiome\, and host biology in the context of health and disease. And Senior VP of Research at Finch Therapeutics\, Dr. Sonia Timberlake\, will join us for an inspiring keynote on present opportunities for technical innovation and clinical impact at the interface of microbiome and oncology research. \nAn outdoor reception will immediately follow\, providing networking opportunities for investigators and trainees from both research centers. \nNOTE: Attendees are required to register through Eventbrite in advance. Attendance will be managed through the MIT COVIDpass system. All in-person attendees must be a registered COVIDpass user OR non-MIT affiliates must register for a Tim Ticket. \n\nProgram Overview\nKeynote Address \nSonia Timberlake\, PhD\nSenior VP of Research\, Finch Therapeutics \n\nResearch Presentations \nÖmer H. Yilmaz\, MD\, PhD\nEisen and Chang Career Development Professor\nAssociate Professor of Biology \n\nMathilde Poyet\, PhD and Mathieu Groussin\, PhD\nPost-doctoral Fellows\, MIT BE\nScientific Directors & Founders\, Global Microbiome Conservancy \n\nLaura Kiessling\, PhD\nNovartis Professor of Chemistry
URL:https://scienceinboston.com/event/microbiome-in-oncology-symposium-2/
LOCATION:Koch Institute for Integrative Cancer Research\, 500 Main Street\, Cambridge\, MA\, 02142\, United States
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211110T160000
DTEND;TZID=America/Toronto:20211110T164500
DTSTAMP:20211029T162610Z
CREATED:20211029T162610Z
LAST-MODIFIED:20211029T162610Z
UID:17190-1636560000-1636562700@scienceinboston.com
SUMMARY:STEMCELL Cambridge Career Open House
DESCRIPTION:Join our virtual career open house to learn more about becoming a Scientific Sales or Scientific Support Representative at STEMCELL Technologies. We’re looking for enthusiastic and science-oriented people to join our team based in Cambridge\, MA. \n\n\n\nTime: Wednesday\, November 10\, 2021\, 4:00 – 4:45 p.m.\n\nLocation: Zoom Meeting – A virtual meeting invite will be sent to you
URL:https://scienceinboston.com/event/stemcell-cambridge-career-open-house/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2021/10/CR385-Virtual-Open-House-Cambridge-form.jpg
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211110T160000
DTEND;TZID=America/Toronto:20211110T164500
DTSTAMP:20211029T162610Z
CREATED:20211029T162610Z
LAST-MODIFIED:20211029T162610Z
UID:27768-1636560000-1636562700@scienceinboston.com
SUMMARY:STEMCELL Cambridge Career Open House
DESCRIPTION:Join our virtual career open house to learn more about becoming a Scientific Sales or Scientific Support Representative at STEMCELL Technologies. We’re looking for enthusiastic and science-oriented people to join our team based in Cambridge\, MA. \n\n\n\nTime: Wednesday\, November 10\, 2021\, 4:00 – 4:45 p.m.\n\nLocation: Zoom Meeting – A virtual meeting invite will be sent to you
URL:https://scienceinboston.com/event/stemcell-cambridge-career-open-house-2/
LOCATION:Online
ATTACH;FMTTYPE=image/jpeg:https://scienceinboston.com/wp-content/uploads/sites/6/2021/10/CR385-Virtual-Open-House-Cambridge-form.jpg
ORGANIZER;CN="STEMCELL Technologies":MAILTO:info@stemcell.com
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211113T180000
DTEND;TZID=America/Toronto:20211113T210000
DTSTAMP:20211022T215018Z
CREATED:20211022T215018Z
LAST-MODIFIED:20211022T215018Z
UID:17061-1636826400-1636837200@scienceinboston.com
SUMMARY:High Hopes Gala
DESCRIPTION:In celebration of the 100th anniversary of the discovery of insulin\, we are proud to honor the top 100 individuals\, advancements\, groups\, corporations and foundations that we\, at Joslin\, admire and appreciate for their impact on the diabetes community over the last century. We are grateful for their innovation\, imagination and advocacy that has allowed for new discoveries in the journey to find a cure. \nThis year’s Gala will take place as a live broadcast from our studio location. Our guests will have the unique opportunity to view the event as it unfolds from the comfort and safety of their own homes. You won’t want to miss this! \nThis distinctive event raises funds for Joslin’s High Hopes Fund\, which directly supports Joslin’s most important efforts to identify breakthrough advancements in diabetes research and clinical care. The High Hopes Fund provides immediate support of our most critical needs- whether that’s funding a promising new research project\, educating a patient on new technology or supporting patient care that seamlessly address all areas of a complex disease. \nWe hope you will join us in celebration of Joslin’s mission so we don’t have to wait another 100 years for a cure.
URL:https://scienceinboston.com/event/high-hopes-gala/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211113T180000
DTEND;TZID=America/Toronto:20211113T210000
DTSTAMP:20211022T215018Z
CREATED:20211022T215018Z
LAST-MODIFIED:20211022T215018Z
UID:27758-1636826400-1636837200@scienceinboston.com
SUMMARY:High Hopes Gala
DESCRIPTION:In celebration of the 100th anniversary of the discovery of insulin\, we are proud to honor the top 100 individuals\, advancements\, groups\, corporations and foundations that we\, at Joslin\, admire and appreciate for their impact on the diabetes community over the last century. We are grateful for their innovation\, imagination and advocacy that has allowed for new discoveries in the journey to find a cure. \nThis year’s Gala will take place as a live broadcast from our studio location. Our guests will have the unique opportunity to view the event as it unfolds from the comfort and safety of their own homes. You won’t want to miss this! \nThis distinctive event raises funds for Joslin’s High Hopes Fund\, which directly supports Joslin’s most important efforts to identify breakthrough advancements in diabetes research and clinical care. The High Hopes Fund provides immediate support of our most critical needs- whether that’s funding a promising new research project\, educating a patient on new technology or supporting patient care that seamlessly address all areas of a complex disease. \nWe hope you will join us in celebration of Joslin’s mission so we don’t have to wait another 100 years for a cure.
URL:https://scienceinboston.com/event/high-hopes-gala-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211116T190000
DTEND;TZID=America/Toronto:20211116T200000
DTSTAMP:20211103T194858Z
CREATED:20211103T194858Z
LAST-MODIFIED:20211103T194858Z
UID:17258-1637089200-1637092800@scienceinboston.com
SUMMARY:How Fundamental Science Becomes Treatment at Boston Children's Hospital: A Conversation with Kevin Churchwell
DESCRIPTION:You are invited to join Ruth Lehmann\, President and Director of the Whitehead Institute\, for a series of virtual dialogues with scientific luminaries from academia\, and visionary leaders from the biotech industry. \nWhat trends in science and technology excite them the most? Which innovations have the potential to dramatically impact the way we live and work? \nBe a part of the conversation. \nKevin B. Churchwell\, MD\, is the President and Chief Executive Officer of Boston Children’s Hospital\, providing leadership\, vision\, and oversight for a team that’s dedicated to improving and advancing child health through their life-changing work in clinical care\, research and innovation\, medical education\, and community engagement. \nSince joining Boston Children’s as its Executive Vice President of Health Affairs Chief Operating Officer in 2013\, Dr. Churchwell has been instrumental in leading the hospital’s work to become a High Reliability Organization\, one where zero avoidable harm impacts any patient\, family member\, or employee. He has brought to Boston the same passion for enhancing the patient family experience that defined his tenure as CEO of both Nemours/Alfred I. duPont Hospital for Children in Wilmington\, DE\, and Monroe Carell Jr. Children’s Hospital\, part of the Vanderbilt University Medical Center in Nashville\, TN. \nAn advocate for equity\, diversity and inclusivity\, Dr. Churchwell is responsible for establishing three of the 11 Offices of Health Equity and Inclusion at hospitals across the U.S. and Canada\, including the Office at Boston Children’s\, which he founded in 2016. With the publication of Boston Children’s own Declaration for Equity\, Diversity and Inclusivity in 2020\, Dr. Churchwell has committed to the work required to make Boston Children’s a community that’s made stronger by our differences\, and a leader in equity for all. \nA graduate of Massachusetts Institute of Technology and Vanderbilt Medical School in Nashville\, Dr. Churchwell completed his pediatric residency and a clinical fellowship in Pediatric Critical Care at Boston Children’s Hospital. He is currently an Associate Professor of Pediatric Anesthesia at Harvard Medical School and Dr. Churchwell is the Robert and Dana Smith Associate Professor of Anesthesia at the Harvard Medical School.
URL:https://scienceinboston.com/event/how-fundamental-science-becomes-treatment-at-boston-childrens-hospital-a-conversation-with-kevin-churchwell/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211116T190000
DTEND;TZID=America/Toronto:20211116T200000
DTSTAMP:20211103T194858Z
CREATED:20211103T194858Z
LAST-MODIFIED:20211103T194858Z
UID:27770-1637089200-1637092800@scienceinboston.com
SUMMARY:How Fundamental Science Becomes Treatment at Boston Children's Hospital: A Conversation with Kevin Churchwell
DESCRIPTION:You are invited to join Ruth Lehmann\, President and Director of the Whitehead Institute\, for a series of virtual dialogues with scientific luminaries from academia\, and visionary leaders from the biotech industry. \nWhat trends in science and technology excite them the most? Which innovations have the potential to dramatically impact the way we live and work? \nBe a part of the conversation. \nKevin B. Churchwell\, MD\, is the President and Chief Executive Officer of Boston Children’s Hospital\, providing leadership\, vision\, and oversight for a team that’s dedicated to improving and advancing child health through their life-changing work in clinical care\, research and innovation\, medical education\, and community engagement. \nSince joining Boston Children’s as its Executive Vice President of Health Affairs Chief Operating Officer in 2013\, Dr. Churchwell has been instrumental in leading the hospital’s work to become a High Reliability Organization\, one where zero avoidable harm impacts any patient\, family member\, or employee. He has brought to Boston the same passion for enhancing the patient family experience that defined his tenure as CEO of both Nemours/Alfred I. duPont Hospital for Children in Wilmington\, DE\, and Monroe Carell Jr. Children’s Hospital\, part of the Vanderbilt University Medical Center in Nashville\, TN. \nAn advocate for equity\, diversity and inclusivity\, Dr. Churchwell is responsible for establishing three of the 11 Offices of Health Equity and Inclusion at hospitals across the U.S. and Canada\, including the Office at Boston Children’s\, which he founded in 2016. With the publication of Boston Children’s own Declaration for Equity\, Diversity and Inclusivity in 2020\, Dr. Churchwell has committed to the work required to make Boston Children’s a community that’s made stronger by our differences\, and a leader in equity for all. \nA graduate of Massachusetts Institute of Technology and Vanderbilt Medical School in Nashville\, Dr. Churchwell completed his pediatric residency and a clinical fellowship in Pediatric Critical Care at Boston Children’s Hospital. He is currently an Associate Professor of Pediatric Anesthesia at Harvard Medical School and Dr. Churchwell is the Robert and Dana Smith Associate Professor of Anesthesia at the Harvard Medical School.
URL:https://scienceinboston.com/event/how-fundamental-science-becomes-treatment-at-boston-childrens-hospital-a-conversation-with-kevin-churchwell-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211117T170000
DTEND;TZID=America/Toronto:20211117T180000
DTSTAMP:20211022T230241Z
CREATED:20211022T225956Z
LAST-MODIFIED:20211022T230241Z
UID:17083-1637168400-1637172000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Najat Khan\, Janssen R&D
DESCRIPTION:BIES is a monthly conversation about medicine\, biology\, computers\, and entrepreneurship. \nFeatured Speaker \nNajat S. Khan\, PhD\, is Chief Data Science Officer for Janssen R&D Data Sciences\, and Global Head of Janssen R&D Strategy and Operations. \nAs Chief Data Science Officer at Janssen Research & Development\, Najat is responsible for identifying and executing high-impact initiatives across Discovery and Development\, including by curating external partnerships that enrich data availability and enable rapid deployment and scale. These data science efforts span Janssen’s portfolio\, including a key role in COVID-19 vaccine development. Najat also serves as Global Head of Janssen R&D Strategy & Operations and co-leads the cross-sector J&J Data Science Council. Najat received her B.A. in Chemistry from Colgate University and her Ph.D. in Organic Chemistry from the University of Pennsylvania.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-najat-khan-janssen-rd-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211117T170000
DTEND;TZID=America/Toronto:20211117T180000
DTSTAMP:20211022T225956Z
CREATED:20211022T225956Z
LAST-MODIFIED:20211022T225956Z
UID:27764-1637168400-1637172000@scienceinboston.com
SUMMARY:Biomedical Informatics Entrepreneurs Salon: Najat Khan\, Janssen R&D
DESCRIPTION:BIES is a monthly conversation about medicine\, biology\, computers\, and entrepreneurship. \nFeatured Speaker \nNajat S. Khan\, PhD\, is Chief Data Science Officer for Janssen R&D Data Sciences\, and Global Head of Janssen R&D Strategy and Operations. \nAs Chief Data Science Officer at Janssen Research & Development\, Najat is responsible for identifying and executing high-impact initiatives across Discovery and Development\, including by curating external partnerships that enrich data availability and enable rapid deployment and scale. These data science efforts span Janssen’s portfolio\, including a key role in COVID-19 vaccine development. Najat also serves as Global Head of Janssen R&D Strategy & Operations and co-leads the cross-sector J&J Data Science Council. Najat received her B.A. in Chemistry from Colgate University and her Ph.D. in Organic Chemistry from the University of Pennsylvania.
URL:https://scienceinboston.com/event/biomedical-informatics-entrepreneurs-salon-najat-khan-janssen-rd-2-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211119T123000
DTEND;TZID=America/Toronto:20211119T140000
DTSTAMP:20211022T230513Z
CREATED:20211022T230513Z
LAST-MODIFIED:20211022T230513Z
UID:17086-1637325000-1637330400@scienceinboston.com
SUMMARY:What We Can Learn from the ACE2 Cellular Receptor – Past\, Present\, and Future?
DESCRIPTION:This monthly seminar series explores issues at the intersection of ethics\, technology\, and bioscience with an eye toward practical approaches\, policies and ethical responsibilities. \nJoin us online for the November Ethics in Research and Biotechnology Consortium discussing “What We Can Learn from the ACE2 Cellular Receptor – Past\, Present\, and Future?” with Josef Penninger\, MD.
URL:https://scienceinboston.com/event/what-we-can-learn-from-the-ace2-cellular-receptor-past-present-and-future/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211119T123000
DTEND;TZID=America/Toronto:20211119T140000
DTSTAMP:20211022T230513Z
CREATED:20211022T230513Z
LAST-MODIFIED:20211022T230513Z
UID:27765-1637325000-1637330400@scienceinboston.com
SUMMARY:What We Can Learn from the ACE2 Cellular Receptor – Past\, Present\, and Future?
DESCRIPTION:This monthly seminar series explores issues at the intersection of ethics\, technology\, and bioscience with an eye toward practical approaches\, policies and ethical responsibilities. \nJoin us online for the November Ethics in Research and Biotechnology Consortium discussing “What We Can Learn from the ACE2 Cellular Receptor – Past\, Present\, and Future?” with Josef Penninger\, MD.
URL:https://scienceinboston.com/event/what-we-can-learn-from-the-ace2-cellular-receptor-past-present-and-future-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T130000
DTSTAMP:20211119T210325Z
CREATED:20211119T210325Z
LAST-MODIFIED:20211119T210325Z
UID:17582-1638273600-1638277200@scienceinboston.com
SUMMARY:Regulatory Science Forum: New Funding and Business Models for Accelerating Biomedical Innovation
DESCRIPTION:Most experts agree that we are in the midst of a golden age of biomedical innovation. Technologies breakthroughs such as next-generation sequencing\, gene editing\, immunotherapies\, mRNA technology\, and AI-enhanced drug discovery have permanently changed the way we treat diseases. However\, the funding and business models we use to commercialize these technologies are still largely the same\, making it particularly challenging for younger scientists to bring their ideas into practice. In this talk\, Dr. Andrew Lo – Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management – will describe the financial considerations that create bottlenecks in the commercialization process and discuss current and emerging solutions\, including venture philanthropy\, portfolio companies\, and securitization techniques. No finance background is assumed\, but attendees should be prepared to participate in one or two live financial transactions during the seminar.
URL:https://scienceinboston.com/event/regulatory-science-forum-new-funding-and-business-models-for-accelerating-biomedical-innovation/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Vancouver:20211130T120000
DTEND;TZID=America/Vancouver:20211130T130000
DTSTAMP:20211119T210325Z
CREATED:20211119T210325Z
LAST-MODIFIED:20211119T210325Z
UID:27777-1638273600-1638277200@scienceinboston.com
SUMMARY:Regulatory Science Forum: New Funding and Business Models for Accelerating Biomedical Innovation
DESCRIPTION:Most experts agree that we are in the midst of a golden age of biomedical innovation. Technologies breakthroughs such as next-generation sequencing\, gene editing\, immunotherapies\, mRNA technology\, and AI-enhanced drug discovery have permanently changed the way we treat diseases. However\, the funding and business models we use to commercialize these technologies are still largely the same\, making it particularly challenging for younger scientists to bring their ideas into practice. In this talk\, Dr. Andrew Lo – Charles E. and Susan T. Harris Professor at the MIT Sloan School of Management – will describe the financial considerations that create bottlenecks in the commercialization process and discuss current and emerging solutions\, including venture philanthropy\, portfolio companies\, and securitization techniques. No finance background is assumed\, but attendees should be prepared to participate in one or two live financial transactions during the seminar.
URL:https://scienceinboston.com/event/regulatory-science-forum-new-funding-and-business-models-for-accelerating-biomedical-innovation-2/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211130T160000
DTEND;TZID=America/Toronto:20211130T170000
DTSTAMP:20211115T015614Z
CREATED:20211115T015614Z
LAST-MODIFIED:20211115T015614Z
UID:17479-1638288000-1638291600@scienceinboston.com
SUMMARY:How Cancer Spreads
DESCRIPTION:For two decades\, we have understood how normal human cells can be converted in cancer cells and form primary tumors. But it has been unclear what mechanisms allow primary tumors to become actively malignant and life-threatening. \nRecently\, though\, insights into cellular programs that operate during embryo formation and wound healing have yielded clues to how primary cancer cells learn to invade nearby tissues and spread throughout the body.\nThis webinar will focus on the next\, challenging question: How do cancer cells arising in one tissue learn to adapt and proliferate in tissues to which they have spread through metastasis?
URL:https://scienceinboston.com/event/how-cancer-spreads/
LOCATION:Online
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Toronto:20211130T160000
DTEND;TZID=America/Toronto:20211130T170000
DTSTAMP:20211115T015614Z
CREATED:20211115T015614Z
LAST-MODIFIED:20211115T015614Z
UID:27771-1638288000-1638291600@scienceinboston.com
SUMMARY:How Cancer Spreads
DESCRIPTION:For two decades\, we have understood how normal human cells can be converted in cancer cells and form primary tumors. But it has been unclear what mechanisms allow primary tumors to become actively malignant and life-threatening. \nRecently\, though\, insights into cellular programs that operate during embryo formation and wound healing have yielded clues to how primary cancer cells learn to invade nearby tissues and spread throughout the body.\nThis webinar will focus on the next\, challenging question: How do cancer cells arising in one tissue learn to adapt and proliferate in tissues to which they have spread through metastasis?
URL:https://scienceinboston.com/event/how-cancer-spreads-2/
LOCATION:Online
END:VEVENT
END:VCALENDAR